| Date Filed | Type | Description |
| 02/26/2015 |
8-K
| Entry into a Material Definitive Agreement |
| 03/12/2014 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"ProUroCare Medical Inc. To Delist From The OTCQB And Deregister Its Common Stock, Units and Warrants MINNEAPOLIS — ProUroCare Medical Inc., a Nevada Corporation , developer of the FDA-approved ProUroScan™ prostate imaging system, announced today that it intends to remove its common stock from trading on the OTCQB and to file a Form 15 with the Securities and Exchange Commission on or about March 14, 2014. The Company also announced that because its common stock, warrants and units are held by less than 300 holders of record and were held by less than 300 holders of record as of January 1, 2014, it expects to terminate the registration of its common stock, warrants and units under Section 12 and to suspend its reporting obligations under Section 15 of the Securities Exchange Act of 1934, as..." |
|
| 02/12/2014 |
8-K
| Resignation/termination of a director |
| 09/09/2013 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/26/2013 |
8-K
| Quarterly results |
| 05/01/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
| 04/19/2013 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/28/2013 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 11/30/2012 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 11/05/2012 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/18/2012 |
8-K
| Investor presentation |
| 08/28/2012 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/10/2012 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 07/05/2012 |
8-K
| Form 8-K - Current report |
| 05/25/2012 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 04/04/2012 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 01/23/2012 |
8-K
| Form 8-K - Current report |
| 12/28/2011 |
8-K
| Form 8-K - Current report |
| 11/17/2011 |
8-K
| Form 8-K - Current report |
| 11/04/2011 |
8-K
| Form 8-K - Current report |
| 10/17/2011 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/15/2011 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/15/2011 |
8-K/A
| Appointed a new director |
| 07/01/2011 |
8-K
| Form 8-K - Current report |
| 05/17/2011 |
8-K
| Form 8-K - Current report |
| 04/21/2011 |
8-K
| Form 8-K - Current report |
| 02/14/2011 |
8-K
| Form 8-K - Current report |
| 01/21/2011 |
8-K
| Form 8-K - Current report |
| 10/05/2010 |
8-K
| Form 8-K - Current report |
| 09/29/2010 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits|
Docs:
|
"$3,125,000 Securities Purchase Agreement by and between ProUroCare Medical Inc. and Seaside 88, LP (filed herewith)",
"UPDATE -ProUroCare Announces $3 Million Financing Agreement MINNEAPOLIS, Minn. – ProUroCare Medical Inc. , a provider of proprietary imaging products, today announced the signing of an agreement for $3.125 million in equity financing with Seaside 88, LP of Juno Beach, Fla. The proceeds of the financing will be used to expand the company's product portfolio and to support scale-up activities associated with final preparation, manufacturing and eventual marketing of the ProUroScan™ prostate imaging system following FDA clearance. The company's first product is currently under review by the FDA as a "de novo" filing, and a portion of this funding will be used to support operations during the ongoing FDA review period. This funding brings the total amount of money raised by ProUroCare si..." |
|
| 09/02/2010 |
8-K/A
| Form 8-K - Current report [amend] |
| 08/10/2010 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/02/2010 |
8-K
| Form 8-K - Current report |
| 06/25/2010 |
8-K/A
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
|